Lung Cancer
Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial

Trial in 4,119 peopleInterventions
9.4 years, cohort study, declared no competing interests
The paper
University of Parma; Fondazione IRCCS Istituto Nazionale dei Tumori
Lung Cancer, 21 Sep 2026


